COMMUNIQUÉS West-GlobeNewswire

Bellicum Pharmaceuticals Reports Second Quarter 2018 Financial Results
07/08/2018
Management to host conference call and webcast today at 5 p.m. Eastern HOUSTON, Aug. 07, 2018 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular [...]
Cutera Reports Second Quarter 2018 Financial Results
07/08/2018
Second Quarter Revenue of $42.6 Million, an Increase of 17% Year-over-Year Rest of World System Revenue Grew 26% in the Second Quarter BRISBANE, Calif., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Cutera, Inc. (NASDAQ: CUTR ) (“ [...]
OPKO Health Reports Second Quarter 2018 Financial Results
07/08/2018
Conference Call begins today at 4:30 p.m. Eastern Time MIAMI, Aug. 07, 2018 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ:OPK) reports financial results and business highlights for the three months ended June 30, 2018. [...]
HTG Molecular Diagnostics Reports Second Quarter 2018 Results
07/08/2018
Revenue increased 179% and 190%, respectively, compared to the three and six-month periods in the prior year Call scheduled for today, August 7, at 4:30 pm ET TUCSON, Ariz., Aug. 07, 2018 (GLOBE NEWSWIRE) -- HTG [...]
Tabula Rasa HealthCare Announces Second Quarter 2018 Operating Results
07/08/2018
Second Quarter 2018 Revenue of $48.6 million, growth of 65%; 2018 Revenue Guidance Increased MOORESTOWN, N.J., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ:TRHC), a healthcare [...]
FibroGen Reports Second Quarter 2018 Financial Results
07/08/2018
Roxadustat U.S. Phase 3 Topline Clinical Data Readout on Track for Fourth Quarter of 2018 Feedback from FDA on Pamrevlumab Pivotal Programs in IPF and in Locally Advanced Unresectable Pancreatic Cancer Conference Call [...]
Allena Pharmaceuticals to Present at 2018 Wedbush PacGrow Healthcare Conference
07/08/2018
NEWTON, Mass., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ:ALNA), a late-stage, biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics [...]
Vital Therapies Announces Second Quarter 2018 Financial Results
07/08/2018
- On Track for Release of VTL-308 Topline Results in Second Half of September 2018 SAN DIEGO, Aug. 07, 2018 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq: VTL), a biotherapeutic company developing ELAD®, a cell- [...]
Nuvectra™ Reports Second Quarter 2018 Financial Results
07/08/2018
Reports Record Algovita® Sales of $11.5 million, Up 110% YoY PLANO, Texas, Aug. 07, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today financial [...]
Xenon Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Corporate Update
07/08/2018
Novel Epilepsy Product Candidates – XEN1101 and XEN901 – Continue to Advance in the Clinic New XEN1101 Phase 1b TMS Pharmacodynamic Data to be Presented at upcoming European Congress on Epileptology BURNABY, British [...]
Flexion Therapeutics Reports Second-Quarter 2018 Financial Results and Recent Business Highlights
07/08/2018
Company reported net ZILRETTA ® ( triamcinolone acetonide extended-release injectable suspension) sales of $3.8 million in Q2 representing 73% growth over Q1 Strong progress on the ZILRETTA commercial launch: 60% of [...]
Sientra Reports Second Quarter 2018 Financial Results
07/08/2018
Achieves Record Net Sales of $17.6 Million Appoints Patrick F. Williams to General Manager of miraDry Business Segment Appoints Aesthetics Veteran Paul Little as Chief Financial Officer SANTA BARBARA, Calif., Aug. 07, [...]
MyoKardia to Present at the 2018 Wedbush Pacgrow Healthcare Conference
07/08/2018
SOUTH SAN FRANCISCO, Calif., Aug. 07, 2018 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq:MYOK), a clinical-stage biopharmaceutical company pioneering a precision medicine approach for the treatment of heritable [...]
MacroGenics Provides Update on Corporate Progress and 2nd Quarter 2018 Financial Results
07/08/2018
ROCKVILLE, Md., Aug. 07, 2018 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for [...]
GW Pharmaceuticals plc Reports Fiscal Third Quarter 2018 Financial Results and Operational Progress
07/08/2018
- Epidiolex ® (cannabidiol) oral solution approved by FDA and on track to be launched in Fall - - Conference call today at 4:30 p.m. ET - LONDON and CARLSBAD, Calif., Aug. 07, 2018 (GLOBE NEWSWIRE) -- GW Pharmaceuticals [...]
CytomX to Present at the 2018 Wedbush PacGrow Healthcare Conference
07/08/2018
SOUTH SAN FRANCISCO, Calif., Aug. 07, 2018 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investigational antibody [...]
Verrica Reports Second Quarter 2018 Financial Results
07/08/2018
WEST CHESTER, Pa., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a pharmaceutical company focused on identifying, developing and commercializing innovative pharmaceutical [...]
Genesis Healthcare Reports Strong Second Quarter 2018 Results
07/08/2018
KENNETT SQUARE, Pa., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Genesis Healthcare, Inc. (Genesis, or the Company) (NYSE:GEN), one of the largest post-acute care providers in the United States, today announced operating results [...]
Eloxx Pharmaceuticals Reports Second Quarter 2018 Financial and Operating Results and Provides Business Update
07/08/2018
CTA approved in Belgium and IND open in the U.S. for investigational drug candidate, ELX-02 On track to initiate Phase 2 clinical trials in cystic fibrosis and cystinosis in 2018 Expanded Leadership Team with Global [...]

Pages